Overview A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee Status: Completed Trial end date: 2016-09-01 Target enrollment: Participant gender: Summary The Primary objective of this study is to evaluate the efficacy of VX-150 in the treatment of osteoarthritis pain Phase: Phase 2 Details Lead Sponsor: Vertex Pharmaceuticals Incorporated